Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.56 USD | -2.26% | +5.28% | -12.82% |
07/05 | Beam Therapeutics Shares Fall After Q1 Revenue Misses Estimates | MT |
07/05 | Beam Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.82% | 1.9B | |
+29.46% | 49.46B | |
+0.70% | 42.58B | |
+48.83% | 42.49B | |
-5.26% | 29.09B | |
+12.42% | 26.61B | |
-24.25% | 18.64B | |
+7.26% | 13.16B | |
+31.96% | 12.55B | |
+23.79% | 12.1B |
- Stock Market
- Equities
- BEAM Stock
- News Beam Therapeutics Inc.
- RBC Cuts Price Target on Beam Therapeutics to $42 From $50, Maintains Sector Perform, Speculative Risk Rating